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Aging is associated with biomechanical and physiological changes in several organ systems, 
including neural changes of voluntary movement.  One manifestation of age-related changes in 
neural control of gait is the increased activation of muscles that are antagonist to the prime 
movers during the stance phase of gait.  Another age-related adaptation is the increased 
metabolic cost of locomotion.  Several studies have attempted to link gait mechanics to the 
increased cost of transport, but none of the mechanical gait variables accounted for the age-
related increase in oxygen uptake.  Here we hypothesized that the related increase in metabolic 
cost during gait is mediated by increased antagonist muscle coactivation.  EMG and oxygen 
consumption data were collected during treadmill walking to determine the levels of antagonist 
muscle coactivation and metabolic cost.  The data revealed that old subjects experienced 
significantly greater levels of both coactivation and metabolic cost.  Old subjects had 4-17% 
greater levels of metabolic cost of gait than young subjects, and 53-61% greater levels of total 
antagonist muscle coactivation than young subjects.  Regression analyses showed that there was 
a strong association between the level of antagonist muscle coactivation and metabolic cost of 
gait, suggesting that neural factors contribute to the age-related metabolic adaptations in gait. 
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CHAPTER I:  INTRODUCTION 
 Population distribution in the United States has been drastically changing.  Every year the 
United States has a greater percentage of old individuals within its demographics.  In the year 
1993 the average life expectancy was 76.  By 2050 the average life expectancy is estimated to be 
somewhere between 82 and 87 years old (US Census Bureau).  As the United States population 
increases in age it is necessary to promote research to address concerns that coincide with aging.  
This type of research will help physicians and other professionals to provide proper care that 
older populations require. 
 Research has shown that as people age, their bodies naturally go through changes 
involving nearly every anatomical system.  One of these physiological changes involves changes 
in neural control of voluntary movement, specifically increases in antagonist muscle 
coactivation.  This increased muscle coactivation, which is the concurrent activation of pairs of 
muscles on the opposite side of a joint is caused by both cortical and spinal changes within the 
nervous system.  There are several functional roles of muscle coactivation including increasing 
joint stiffness, increasing joint stability (Hortobagyi and DeVita 2000), assisting with learning 
new skills (Person and Roshchina 1958), and decreasing reaction time (Park 2002). 
 Another change that old adults experience with locomotion is an increase in energy 
consumption.  Old individuals use more oxygen and work at a higher percentage of their 
maximal oxygen uptake (VO2 max) during gait as compared to younger individuals (Malatesta, 
D., D.Simar et al. 2004).  This occurs when older individuals walk at both absolute and self-
selected gait velocities.  This increase in metabolic energy could be caused by many factors 
including changes in mitochondrial function, and muscle sarcopenia, and decreased cardiac 
output. 
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 It is possible that one of the other physiological changes associated with the increase in 
energy consumption old people experience is increased antagonist muscle coactivation.  When 
people perform voluntary movements with high levels of muscle coactivation they are activating 
a larger muscle mass than needed to perform the task, which will in turn increase oxygen and 
energy demands.  Additionally since the antagonist muscles are producing more force, the 
agonist muscles need to contract more forcefully in order to overcome that force.  This should 
increase the oxygen and energy demands of a person, because greater levels of ATP need to be 
produced in both agonist and antagonist muscles. 
Hypothesis 
Several hypotheses were investigated within this study.  The global hypothesis was that 
the age related increase in oxygen consumption was caused by increased antagonist muscle 
coactivation during normal gait.  The first sub-hypothesis was that an age effect would be present 
in which old adults would experience greater levels of both metabolic cost of gait and antagonist 
muscle coactivation. The second sub-hypothesis was that as gait velocity increased antagonist 
muscle coactivation also increased.  Finally, the third sub-hypothesis was that there would be a 
task main effect; decline walking would cause greater levels of coactivation than incline walking. 
Purpose 
 The purpose of this study was to compare the cost of locomotion and EMG muscle 
activity in antagonist muscles in old and young adults during gait, and to determine if there was a 
relationship between the metabolic cost of motion and the amount of antagonist muscle 
coactivation during this motion. 
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Delimitations 
1) All subjects were healthy and free of pain during normal gait.  They had no history of 
lower extremity injury.  Additionally they were free of neurological disorders, 
cardiovascular disease, and musculoskeletal problems. 
2) Subjects were men and women, and had a Body Mass Index of <30 kg/m² 
3) Subjects had normal function in activities of daily living. 
4) The study looked at EMG activity in one leg during 1 resting condition and 5 walking 
conditions for six minutes. 
5) Young subjects were 18 – 25, and old subjects were 70 – 85. 
Limitations 
1) The Cosmed mask may not have always completely and perfectly sealed around a 
subject’s face. 
2) The EMG signals could have been affected by biological tissue content. 
3) Some subjects were not completely comfortable walking on the treadmill, and may have 
altered their normal gait. 
4) The subjects may have felt restricted or weighed down by the Cosmed equipment.  
5) The study looked at self selected, slow, fast, incline, and decline walking conditions. 
Operational Definitions 
Young adult:  males and females 18-25 years of age 
Old adults:  males and females 70-85 years of age 
Muscle coactivation:  the average antagonist muscle activity level when the agonist is 
contracting.  This value was normalized to the subjects’ maximal voluntary contraction. 
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CHAPTER II:  REVIEW OF THE LITERATURE 
Cost of Locomotion in Old Adults 
 Cost of locomotion is defined as how much energy is necessary to move from one place 
to another.  It is dependent on many things including locomotion speed, fitness level, and age.  
Old individuals use more energy to walk a given distance than young individuals (McCann and 
Adams 2002; Malatesta, Simar et al. 2003). 
 One possible reason for increased metabolic cost of gait in old adults may be due to 
decreased mitochondrial function.  The mitochondria are constantly generating reactive oxygen 
species that eventually damage the mitochondrial DNA (mtDNA) (Harman 2003).  These 
changes in the mtDNA eventually cause dysfunction in the electron transport system which 
reduces the ATP production of the mitochondria (Dirks, Hofer et al. 2006).  Mitochondrial 
dysfunction may cause cell death which in turn mediates neurodegeneration and sarcopenia 
(Marzetti and Leeuwenburgh 2006).  Mitochondrial dysfunction and cell death means that old 
individuals yield fewer ATP from the electron transport system.  This inefficiency causes old 
adults to use more oxygen and have greater metabolic cost than young adults. 
 However, even though mitochondrial dysfunction occurs it isn’t the main contributor to 
increased cost of locomotion in older individuals.  As people age the mitochondrial dysfunction 
they experience mainly occurs in type II muscle fibers, while mitochondria in old people’s type I 
muscle fibers actually become more efficient (Deschenes 2004).  Therefore, mitochondrial 
dysfunction is not the sole cause for age related increases in energy consumption.  The exact 
cause of the increased cost of locomotion that old individuals experience is still debatable.  
However, the fact that old adults experience increased antagonist muscle coactivation, thereby 
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activating and using more muscles than young individuals, may in fact play a role in increased 
metabolic cost of gait. 
Mechanical Parameters of the Cost of Locomotion 
 Some researchers have previously speculated that an increase in metabolic cost of 
locomotion was due to changes in the mechanics of gait that older individuals experienced.  
Cross sectional data has indicated that when energy consumption during locomotion increases 
biomechanical changes in gait also occur Waters, Lunsford et al. 1988).  Old adults may alter 
their patterns of locomotion thereby changing the normal kinetic and potential energies that they 
utilize, or they may have to use more energy to stabilize their body during locomotion. 
 Old adults actively change and control their step width more than young adults (Donelan, 
Shipman et al. 2004).  This allows them to alter the level of stability used during gait.  Old adults 
stabilize their joints more during walking, by increasing their step width.  They tend to take 
wider steps and adjust their step width more frequently than young individuals (Owings and 
Grabiner 2004).  Altering step width ultimately requires people to use more mechanical energy 
and also forces them to consume more oxygen (Donelan, Shipman et al. 2004). 
 In addition to altering their step width and stability, old adults also change their walking 
mechanics which may lead to changes in oxygen consumption.  Old adults perform more 
positive work on their center of mass than young individuals during most gait phases 
(Hernandez, Silder et al. 2009).  It has also been shown that as people age they have a shift in 
joint forces.  Old individuals have higher joint torques and powers in their hips and knees than 
young individuals (DeVita and Hortobagyi 2000). 
 The mechanical changes that old adults experience may be taxing in terms of energy 
consumption, however it is unlikely.  Mian et al. determined that healthy old individuals do not 
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experience a significant increase mechanical work during gait.  Therefore mechanical changes do 
not account for the age related increase in metabolic cost of gait.  Old adults do however 
experience a greater amount of antagonist muscle coactivation, which may be the cause of the 
increased metabolic (Mian, Thom et al. 2006).  
Purpose of Muscle Coactivation 
 Muscles directly involved in producing a desired movement are known as agonist 
muscles.  Those agonists of greatest importance are the prime or principle movers while less 
important agonist muscles are known as assistant movers or synergists. 
 Antagonist muscles have actions opposite of the agonist and are generally located on the 
opposite side of a joint.  In order to be metabolically efficient it is desirable to have the 
antagonist relaxed during the agonist action thereby reducing the amount of active muscle mass 
(Truijens, Noordermeer et al., 2005).  If the antagonist is relaxed, the agonist muscle can exert a 
full amount of joint torque without having to overcome the force produced by the antagonist.  
When both the agonist and antagonist muscles are simultaneously contracting, coactivation 
occurs.  
 Although muscular coactivation can be metabolically costly it does in fact serve several 
purposes.  In 2000 Hortobagyi and DeVita determined that during downward stepping 
individuals began coactivating antagonist muscles before ground contact allowing them to 
prepare for impact.  This preparation was viewed as a protective stabilizing mechanism.  
Antagonist coactivation increases joint stability by increasing the movement control in a joint.  
Muscular contractions on both sides of a joint make the joint more rigid by creating tension 
around it.  This increases joint stability, especially in motions that require eccentric muscle 
contractions (Hortobagyi and DeVita 2000).  Increased joint stability through coactivation 
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decreases the risk of injury and can also increase the longevity of a joint.  Previous research has 
also shown that during faster joint movements antagonist muscle activation increases in order to 
provide better joint stability for individuals (Zijlstra 2004).  This study looked at how both the 
type of muscle contraction during gait, and the velocity during gait affected antagonist muscle 
coactivation 
 Coactivation also provides increased coordination.  Person et al. found that when learning 
a new task individuals increased coactivation for better control over the task movement, and then 
reduced coactivation when they were comfortable with the task.  Therefore, when people need to 
have careful, coordinated movements they are more likely to increase their muscle coactivation 
(Person and Roshchina 1958).   
Coactivation of the antagonist is also used to moderate the force output of the agonist.  
This is often seen in movements where accuracy is focused on rather than speed.  As a result of 
training or practice, such coactivation is usually reduced (Ives 2006). 
 One way to decrease response time and increase quickness is to use muscular 
coactivation.  When antagonist muscles are pre-activated or already firing, less time is required 
to fully activate them.  Therefore, it is easier to fully activate the antagonist muscles in order to 
change direction or to change the type of movement being performed. 
 Antagonist muscle coactivation exists for many reasons.  However when it occurs it 
could be increasing metabolic cost.  Therefore if coactivation is occurring at a time when it is not 
providing a specific function it is essentially wasting energy for the body.  People are more 
energy efficient when there are minimal levels of muscle coactivation. 
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Muscle Coactivation in Aging 
 As people age their bodies go through many changes, including transformations of their 
nervous systems, and musculoskeletal systems.  These modifications force older adults to adopt 
new ways of performing everyday tasks.  One way that old individuals will change is by 
increasing their antagonist muscle coactivation in both single (Patten and Kamen 2000) and 
multi-joint tasks (Mian, Thom et al. 2006). 
 Reciprocal inhibition is a common neuromuscular phenomenon in which an antagonist 
muscle relaxes while an agonist muscle contracts.  It is mediated by the Ia inhibitory interneuron 
which sends signals to the antagonist muscle telling it to relax.  Old adults experience decreased 
presynaptic inhibition of their Ia inhibitory interneuron (Earles, Vardaxis et al. 2001).  This 
means that a stronger signal from the agonist muscle is required to make the antagonist muscle 
relax in old individuals compared to young individuals.  If a large signal from the agonist muscle 
does not occur, the antagonist muscle won’t be inhibited and will contract, causing muscle 
coactivation to occur. 
 Nielsen proposed that another reason for increased muscle coactivation in old individuals 
was due to afferent and supraspinal pathways converging on the same interneuron.  He 
speculated that interneurons were receiving input from multiple locations which caused them to 
have a higher resting threshold.  Since these interneurons were already slightly excited they 
required a smaller action potential in order to reach threshold.  This means that the interneurons 
fired more frequently in old individuals than in young individuals.  Since interneurons were more 
likely to reach threshold, agonist and antagonist muscles were more likely to contract at the same 
time (Nielsen 2004). 
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 Cortical changes in old individuals also seem to alter antagonist muscle coactivation 
levels.  It has been proposed that in old individuals there is a reduced suppression of areas of the 
brain that control antagonist muscle movement.  In other words, areas of the brain are more 
excited, thereby more likely to cause muscle contractions. 
 Old adults also experience greater overall cortical stimulation during movement 
(Hutchinson, Kobayashi et al. 2002).  This most likely occurs because the cortical and 
subcortical structures are reorganized due to age related neurodegradation.  This degradation 
forces old individuals to actively recruit greater areas of their brain.  When the brain experiences 
greater overall activity it is more likely to cause contraction of both agonist and antagonist 
muscles at the same time. 
 If older adults are in fact experiencing greater antagonist muscle coactivation they in turn 
need to supply energy to those antagonist muscles being used.  This increase in antagonist 
muscle activity may be the reason older adults use more energy for everyday tasks. 
Summary 
It has been proven that old adults coactivate their muscles more than young adults 
(Hortobagyi and DeVita 2000).  This is caused by both spinal and supraspinal mechanisms.  Old 
adults also consume more metabolic energy than young individuals (Mian, Thom et al. 2006).  It 
is important to determine if the age related increase in energy consumption is due to increased 
antagonist muscle coactivation.  This will help researchers and physicians to understand more 
aspects of aging, which is becoming more and more important as the general population 
increases in age. 
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CHAPTER III:  METHODOLOGY 
Subject Characteristics 
 Two groups of 12 subjects were recruited.  The first group consisted young adults (males: 
6, females: 6, age: 20.9± 0.7, BMI: 22.3± 0.4).  The second group of subjects was composed of 
old adults (males: 5, females: 7, age: 77.3± 1.4, BMI: 24.3± 1.0).  Table 1 in the Appendix shows 
the complete subject characteristics. 
Inclusion Criteria 
1) The subjects fell into one of the desired age categories:  young 18-25 years, old 70-90 
years. 
2) Healthy and mobile during gait and other activities. 
3) Free of pain and had no difficulty performing activities of daily living. 
4) A BMI less than or equal to 30.0. 
5) Were able perform all experimental procedures safely and without difficulty. 
6) Provided written informed consent 
Exclusion Criteria 
1) A history of a serious lower extremity injury 
2) Orthopedic problems including osteoporosis, joint replacements, lower extremity or 
back surgery 
3) A history of cardiovascular disease including uncontrolled high blood pressure, a 
history of heart attacks, coronary artery disease, peripheral artery disease, or a 
pacemaker placed in their heart 
4) Neurological abnormalities including stroke, dementia, Parkinson’s disease, etc. 
5) Unable to pass the SPPB 
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6) Could not perform the experimental tasks 
7) Smoked cigarettes within the past 6 months 
Study Design 
 Between group comparisons were made to look at energy consumption data, and 
antagonist EMG data.  These determined if any age main effects were present.  Specifically, they 
determined if old adults had higher metabolic energy consumption, and also if old adults had 
greater antagonist muscle coactivation.  Additionally comparisons were made between velocities 
to determine if a velocity main effect was present for antagonist muscle coactivation levels, and 
comparisons were made between different tasks to see if there was a condition main effect. 
 The subjects performed 6 experimental conditions in which their VO2 and muscle 
activity was measured.  There was a resting, a self-selected walking speed, a fast walking speed, 
a slow walking speed, an incline, and a decline condition.  The data collected during these trials 
was used to determine the subject’s energy consumption and antagonist muscle coactivation.  
Equipment 
 Walking was performed on a Simple 9600 Platform Vision (Vision Fitness) treadmill.  
EMG data was collected by a Bortec EMG system (Bortec Biomedical Ltd.) using 4 channels 
and a ground.  A Cosmed K4b² (Cosmed) VO2 analyzer was worn to collect VO2 data, and 
Cosmed software was used to analyze the VO2 data.  Data were collected with Qualisys Track 
Manager Software (Qualisys, Inc) and analyzed by MatLab (Mathworks). 
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Experimental Protocol 
 Subjects were recruited on campus, by word of mouth, and by newspaper advertisement.  
They participated in a phone interview and went through a movement screening process to 
determine inclusion in the study.  Subjects wore shorts, sneakers, and a heart rate monitor.  
Before testing began subjects were given an informed consent form explaining the experimental 
procedures, any risks, and that they could stop the test at any time.  The informed consent form 
was approved by East Carolina University’s IRB. 
 After signing the informed consent form the subjects completed the short physical 
performance battery protocol and score test (SPPB).  This test determined whether or not a 
person is classified as frail.  If they were frail they were excluded from the study.  Their height 
and weight was taken with their shoes on.   
The subject’s skin was then be prepped for EMG electrodes.  All electrodes were placed 
on the subjects’ right leg.  The skin was shaved and cleansed with an abrasive lemon scrub and 
an alcohol pad at five different electrode sites, four muscle sites and one ground site, in order to 
guarantee good EMG signal conduction.  The electrodes were placed on the distal portion of the 
vastus lateralis (VL), the distal portion of the biceps femoris (BF), the center of the tibialis 
anterior (TA) muscle belly, and the center of the lateral gastrocnemeus (LG) muscle belly.  The 
ground electrode was located on the fibular head. 
Finally the subject wore the Cosmed K4b².  The correct size mask was determined based 
upon a blow test.  During the blow test the subject had the mask strapped to their face.  The 
experimenter covered up the air hole with their hand and asked the subject to exhale as hard as 
they could.  If air escaped the mask either a different size mask was needed, or adjustments to the 
fit of the current mask were made.  They wore the Cosmed analyzer pack on their back. 
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After the subject was outfitted for the experiment they performed manually resisted 
maximal voluntary isometric contractions (MVCs) of each of the four muscles tagged with 
electrodes.  To test the VL subjects sat in a chair with their right knee bent at approximately 60 
degrees.  The tester held the subject’s leg in that position while they pushed against them trying 
to extend their leg.  When testing the BF the tester also held the subject’s leg at approximately 60 
degrees; the subject tried to bend their knee while the tester resisted the motion.  When testing 
the TA the subject had their knee bent at 90 degrees.  They then lifted their toes off the ground 
while keeping their heel in contact with the floor.  The tester tried to push the subject’s toes back 
down to the ground and the subject was forced to resist the motion.  The LG was tested by 
having the tester hold the subject’s leg extended out in front of them in the air.  There was a 
slight bend in the subject’s knee.  The subject tried to plantar flex their foot while the tester 
pushed against their effort.  
The subject was acquainted with the treadmill.  They learned how to properly start and 
stop walking on the treadmill by using its side rails.  If the subject was nervous or felt 
uncomfortable walking on the treadmill they were allowed time to become familiar with walking 
on it. 
There were six conditions each lasting six minutes.  The first condition was always the 
resting condition.  The subject stood calmly for the duration of the trial, as EMG and VO2 data 
were collected.  The second test condition was always walking at a self-selected speed.  During 
this condition the subject walked on a treadmill as it increased in speed.  When the subject felt as 
though they had reached their normal, everyday walking speed they notified the experimenter to 
leave the treadmill at that speed for the duration of the trial.  The remaining four experimental 
conditions were randomized for each subject.  They were level walking at 0.98 m/sec, level 
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walking at 1.2 m/sec, 6% incline at .98 m/sec, and 6% decline at .98 m/sec.  Five minutes into 
each testing condition the subjects was asked to rate how hard they felt that they were working 
on a rating of perceived exertion (RPE) chart.  They will pick a number between 6 and 20.  The 
subjects will rest 3 minutes between each trial. 
Data Analysis 
 All EMG data will be collected at 960 Hz.  The data will first be exported to as a .c3d file 
to Visual3D (C-Motion), where it was exported as a .mat file to MatLab.  There, a program was 
run to determine the amount of antagonist muscle coactivation for each muscle while its agonist 
was active.  The MatLab program that was used to analyze the data was written in conjunction 
with Stanislaw Solnik. 
 In order to determine the amount of antagonist muscle coactivation the program first 
filtered the data with a butterworth bandpass filter (cut-offs of 20 and 350 Hz), and operated 
Teager-Kaiser Operator (TKEO) which enhanced the EMG signal by increasing the signal to 
noise ratio (Solnik, DeVita et al. 2008).  This provided a clearer EMG signal which showed the 
drastic differences between EMG baseline and bursts.  The program allowed the baseline to be 
selected, and then determined exactly when the onset and offset of the agonist muscle activity 
occured.  A muscle burst occurred when EMG activity was greater than 10 standard deviations of 
the selected baseline, and lasted more than 20 msec.  All activity when the agonist muscle was 
inactive was ignored, and EMG envelopes were placed around the agonist muscle bursts.  The 
intensity of the agonist and antagonist muscle contractions within the EMG envelopes were 
normalized to the subjects’ MVCs.  The program then determined the average raw, and average 
normalized EMG amplitude of both the agonist and antagonist muscles while the agonist 
muscles were active.  This was done for each muscle when it was acting as the agonist.  Total 
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coactivation was expressed as the sum of VL, BF, TA, and LG normalized antagonist 
coactivation values. 
 During the test the Cosmed performed a breath by breath analysis of oxygen cost and 
carbon dioxide expenditure.  The data analysis of the metabolic data involved first averaging all 
the metabolic variables into 15 second intervals.  Then the data was averaged by every minute, in 
order to guarantee that subjects reached steady state.  The subjects achieved steady state exercise 
during minute four.  Therefore, the metabolic data in minutes 5 and 6 were averaged together to 
determine the final values for all the metabolic variables. 
 The oxygen consumption data was used to establish the metabolic cost by determining 
the gross metabolic power using the equation  
((16.6 * VO2 Task * 1000 / 60) + 4.51 * (VCO2 Task * 1000 / 60)) / Mass (Brockway 1987) 
Gross metabolic cost per meter using the equation  
(Gross Met Power Task - Gross Met Power Standing) / Velocity.   
These were determined for each minute within the 6 minute trial, however when only the steady 
state values were used in reporting metabolic variables.  Once steady state was reached (minute 
4), each metabolic variable was averaged across the final 2 minutes of the trial (ACSM 
Handbook 2008). 
Statistical Analysis 
 The first statistical analyses were of antagonist muscle coactivation and metabolic data 
during level walking at various velocities.  A group (young, old) by velocity (self-selected, .98 
m/sec, and 1.2 m/sec) analysis of variance with repeated measures for muscle coactivation and 
variables for metabolic cost of gait was performed.  This determined if there was an age main 
effect, velocity main effect, or age by velocity interaction effect.   
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The second statistical analyses were of antagonist muscle coactivation and metabolic data 
during task dependent walking.  A group (young, old) by task (incline, decline) analysis of 
variance with repeated measures for muscle coactivation and variables for metabolic cost of gait 
was performed to determine if there was an age main effect, task main effect, or age by task 
interaction effect. 
Tukey’s Significantly different post-hoc test p < 0.05 was used to determine significane 
for the ANOVA analysis. 
Linear regressions between antagonist muscle coactivation and metabolic cost of gait 
were also performed to directly test the global hypothesis that the age related increase in 
metabolic cost of gait was due to increased antagonist muscle coactivation within old 
individuals. 
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CHAPTER IV:  RESULTS 
 This chapter is separated into the following sections:  1) Metabolic Results of Level 
Walking and Task Dependent Walking, 2) Antagonist Muscle Coactivation Results of Level 
Walking and Task Dependent Walking, 3) Association between Antagonist Muscle Coactivation 
and Metabolic Cost, and 4) Summary. 
 The global hypothesis was that the age related increase in metabolic cost was due to 
increased antagonist muscle coactivation that old individuals experienced.  The first sub-
hypothesis was that an age effect would be evident in metabolic cost and antagonist muscle 
coactivation.  Old subjects would have higher metabolic cost than young individuals, and old 
individuals would also have higher antagonist muscle coactivation than young individuals.  The 
second sub-hypothesis was that there would be a velocity effect in antagonist muscle 
coactivation.  As speed increased, antagonist muscle coactivation would also increase.  The third 
sub-hypothesis was based upon the task.  Decline walking would elicit greater antagonist muscle 
coactivation. 
Metabolic Results of Level and Task Dependent Walking 
 This section addresses the first sub hypothesis which states that old adults have higher 
metabolic cost than young adults.   
During level walking old individuals experienced a significantly greater HR (F = 8.421, p 
= 0.008), RPE (F = 13.859, p = 0.001), VO2 normalized to body weight (F = 7.883, p < 0.001), 
gross metabolic power (F = 6.407, p = 0.019), and gross metabolic energy cost per distance (F = 
4.319, p = 0.050).  Young individuals experienced a significantly greater RER (F = 4.981, p = 
0.036).  These are shown in Figures 1 through 6, and also represented in Table 2 in the 
Appendix. 
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Figure 1.  Age main effect of heart rate during level walking.  Old adults had a significantly 
greater HR than young individuals. * denotes an age main effect. 
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Figure 2.  Age main effect of rating of perceived exertion during level walking.  Old individuals 
had a significantly greater RPE than young individuals.  * denotes an age main effect. 
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Figure 3.  Age main effect of VO2 normalized to body weight during level walking.  Old 
individuals had a significantly greater VO2 than young individuals.  * denotes an age main effect. 
 
0
1
2
3
4
5
6
Y oung Old
G
ro
s
s
 M
e
ta
b
o
li
c
 P
o
w
e
r 
(W
/k
g
)
*
Figure 4.  Age main effect of gross metabolic power during level walking.  Old individuals had a 
significantly greater gross metabolic power than young individuals.  * denotes an age main 
effect. 
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 Figure 5.  Age main effect of gross metabolic energy cost per distance during level walking.  
Old individuals had a significantly greater gross metabolic energy cost per distance than young 
individuals.  * denotes an age main effect. 
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Figure 6.  Age main effect of respiratory exchange ratio during level walking.  Young 
individuals had a significantly greater RER than old individuals.  * denotes an age main effect. 
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During task dependent walking conditions old subjects experienced significantly greater 
HR (F = 6.047, p = 0.005), RPE (F = 9.662, p = 0.005), VO2 normalized to body weight (F = 
4.933, p = 0.037), gross metabolic power (F = 5.854, p = 0.024), and gross metabolic energy cost 
per distance (F = 5.854, p = 0.024).  Young subjects experienced a significantly greater RER (F 
= 4.472 p = 0.046).  These data are shown in Figures 7 through 12, and also in Table 3 in the 
Appendix. 
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Figure 7.  Age main effect of heart rate during incline and decline walking.  Old individuals had 
a significantly greater HR than young individuals.  * denotes an age main effect. 
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Figure 8.  Age main effect of rating of perceived exertion during incline and decline walking.  
Old individuals had a significantly greater RPE than young individuals.  * denotes an age main 
effect. 
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Figure 9.  Age main effect of VO2 normalized to body weight during incline and decline 
walking.  Old individuals had a significantly greater VO2 than young individuals.  * denotes an 
age main effect. 
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Figure 10.  Age main effect of gross metabolic power during incline and decline walking.  Old 
individuals had a significantly greater metabolic power than young individuals.  * denotes an age 
main effect. 
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Figure 11.  Age main effect of gross metabolic energy cost per distance during incline and 
decline walking.  Old individuals had a significantly greater gross metabolic energy cost per 
distance than young individuals.  * denotes an age main effect. 
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Figure 12.  Age main effect of respiratory exchange ratio during incline and decline walking.  
Young individuals had a significantly greater RER than old individuals.  * denotes an age main 
effect. 
 
 Figure 13 shows the percent difference between young and old for each metabolic 
variable in which old individuals had greater values than young individuals. 
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Figure 13. Percent difference between old and young for metabolic variables. 
 
 
Different velocities also affected metabolic variables.  There was a velocity effect in HR 
between .98 and 1.2 m/sec (F = 8.997, p = 0.001).  RPE was significantly greater at a velocity of 
1.2 m/sec compared to both .98 m/sec and self selected velocities (F = 8.997, p = 0.050).  VO2 
was greater at a velocity of 1.2 m/sec compared to both .98 m/sec and self selected velocities (F 
= 14.279, p < 0.001).  When VO2 was normalized to body weight each velocity was significantly 
different from the others (F = 13.707, p = 0.010).  Gross metabolic power was greater at a 
velocity of 1.2 compared to both .98 (F = 12.83 p < 0.001) and self selected (F = 12.83 p = 
0.050) velocities.  Gross metabolic energy cost per distance (F = 11.924 p < 0.001) was 
significantly lower at a velocity of 1.2 m/sec compared to both .98 m/sec and self selected 
velocities.  These data are shown in Figures 14 through 19, and in Table 2. 
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Figure 14.  Velocity main effect of Heart Rate in old and young adults.  HR during 1.2 m/sec was 
significantly greater than HR during .98 m/sec.  ◘ denotes a velocity main effect. 
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Figure 15.  Velocity main effect of rating of perceived exertion in old and young adults.  RPE 
during 1.2 m/sec was significantly greater than RPE during .98 m/sec and self-selected 
velocities.  ◘ denotes a velocity main effect. 
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Figure 16.  Velocity main effect of VO2.  VO2 during 1.2 m/sec was significantly greater than 
VO2 during .98 m/sec and self-selected velocities.  ◘ denotes a velocity main effect. 
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Figure 17.  Velocity main effect of VO2 normalized to body weight in old and young adults.  
VO2 at each velocity was significantly different from the other two velocities.  ◘ denotes a 
velocity main effect 
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Figure 18.  Velocity main effect of gross metabolic power in old and young adults.  Gross 
metabolic power during 1.2 m/sec was significantly greater than metabolic power during .98 
m/sec and self-selected velocities.  ◘ denotes a velocity main effect. 
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Figure 19.  Velocity main effect of gross metabolic energy cost per distance in old and young 
adults.  Metabolic energy cost per distance during 1.2 m/sec was significantly lower than 
metabolic energy cost per distance during .98 m/sec and self-selected velocities.  ◘ denotes a 
velocity main effect. 
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 During task dependent gait, walking at an incline caused subjects to have a significantly 
greater HR (F = 145.734, p < 0.001), RPE (F = 23.032, p < 0.001), VO2 (F = 270.542, p < 
0.001), VO2 normalized to body weight (F = 256.835, p < 0.001), gross metabolic power (F = 
236.489, p < 0.001), and gross metabolic energy cost per distance (F = 236.489, p < 0.001) than 
when they were walking at a decline.  These data are shown in Figures 20 through 25, and Table 
3.  
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Figure 20.  Task main effect of Heart Rate.  HR during Incline was significantly greater than HR 
during decline.  ◘ denotes a task main effect. 
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Figure 21.  Task main effect of RPE.  RPE during Incline was significantly greater than RPE 
during decline.  ◘ denotes a task main effect. 
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Figure 22.  Task main effect of VO2.  VO2 during incline was significantly greater than VO2 
during decline.  ◘ denotes a task main effect. 
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Figure 23.  Task main effect of VO2   normalized to body weight.  VO2 during incline was 
significantly greater than VO2 during decline.  ◘ denotes a task main effect. 
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Figure 24.  Task main effect of gross metabolic power.  Gross metabolic power during incline 
was significantly greater than metabolic power during decline.  ◘ denotes a task main effect. 
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Figure 25.  Task main effect of gross metabolic energy cost per distance.  Gross metabolic 
energy per distance was significantly greater during incline than during decline.  ◘ denotes a 
task main effect. 
 
There were no interaction effects for level walking conditions.  Figures 50- 56 in the 
Appendix show the metabolic variable values. 
 Figure 26 shows the interaction of age and task of RPE.  Old subjects had a greater RPE 
than young subjects in both incline (F = 5.494, p < 0.001) and decline (F = 5.494, p = 0.050) 
conditions.  Additionally old subjects had a significantly greater RPE in incline walking 
compared to their RPE in decline walking (F = 5.494, p < 0.001).   
Figure 27 shows the interaction of age and task of RER.  Young individuals experienced 
greater RPE than old individuals during decline walking (F = 9.837, p < 0.001). 
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There were no other significant age and task interaction effects; however the other 
variables may be seen in Figures 57 through 61 in the Appendix. 
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Figure 26.  Age by task interaction of RPE.  Old incline RPE was significantly greater than 
young incline RPE, old decline RPE, and young decline RPE.  Old decline RPE was significantly 
greater than young decline RPE.  * denotes an age effect.  ◘ denotes a task effect.  ♠ denotes an 
age by task interaction. 
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Figure 27.  Age by task interaction of RER.  Young decline RER was significantly greater than 
old decline RER and old incline RER.  Young incline RER was significantly greater than old 
decline RER.  * denotes an age effect.  ♠ denotes an age by task interaction. 
 
Antagonist Muscle Coactivation Results of Level Walking and Task Dependent Walking 
 To support the first sub-hypothesis old individuals had greater antagonist muscle 
coactivation during level walking at different velocities.  Old adults had significantly greater 
antagonist muscle coactivation of the BF (F = 19.052, p < 0.001), VL (F= 17.536, p <0.001), TA 
(F = 4.531, p =0.045), LG (F = 17.808, p <0.001), and total antagonist muscle coactivation (F = 
31.239, p < 0.001).  These age effects are shown in Figures 28 through 32, and also represented 
in Table 4. 
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 Figure 28.  Age main effect of biceps femoris antagonist muscle coactivation during level 
walking.  Old adults had significantly greater BF antagonist muscle coactivation than young 
adults. * denotes an age main effect. 
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Figure 29.  Age main effect of vastus lateralis antagonist muscle coactivation during level 
walking.  Old adults had a significantly greater VL antagonist muscle coactivation than young 
individuals. * denotes an age main effect 
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Figure 30.  Age main effect of tibialis anterior antagonist muscle coactivation during level 
walking.  Old adults had a significantly greater TA antagonist muscle coactivation than young 
adults. * denotes an age main effect 
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Figure 31.  Age main effect of lateral gastrocnemeus antagonist muscle coactivation during level 
walking.  Old adults had a significantly greater LG antagonist muscle coactivation than young 
individuals. * denotes an age main effect 
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Figure 32.  Age main effect of total antagonist muscle coactivation during level walking.  The 
antagonist muscle coactivation of the BF, VL, TA, and LG normalized to their MVC’s were 
added together to determine the total coactivation.  Old Adults had a significantly greater total 
antagonist muscle coactivation than young individuals. * denotes an age main effect 
 
  
During incline and decline walking old adults had significantly greater antagonist muscle 
coactivation of their BF (F = 50.705, p < 0.001), VL (F = 27.911, p < 0.001), LG (F = 8.040, p 
=0.010), and total antagonist muscle coactivation (F = 59.103, p < 0.001).  These data are shown 
in Figures 33, 34, 36, and 37 respectively.  There was no significant age effect of TA antagonist 
muscle coactivation.  This is shown in Figure 35.  Table 5 in the Appendix also shows these 
values 
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Figure 33.  Age main effect of biceps femoris antagonist muscle coactivation during incline and 
decline walking.  Old adults had significantly greater BF antagonist muscle coactivation than 
young individuals. * denotes an age main effect 
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Figure 34.  Age main effect of vastus lateralis antagonist muscle coactivation during incline and 
decline walking.  Old adults had significantly greater VL antagonist muscle coactivation than 
young individuals. * denotes an age main effect 
  
 
 
 
 
39
 
 
0
1
2
3
4
5
6
7
8
Y oung Old
A
v
e
ra
g
e
 T
ib
ia
li
s
 A
n
te
ri
o
r 
C
o
a
c
ti
v
a
ti
o
n
 (
%
 M
V
C
)
 
Figure 35.  Age main effect of tibialis anterior antagonist muscle coactivation during incline and 
decline walking.  There was no significant age effect present. 
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Figure 36.  Age main effect of lateral gastrocnemeus antagonist muscle coactivation during 
incline and decline walking.  Old adults had significantly greater LG antagonist muscle 
coactivation than young individuals. * denotes an age main effect 
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Figure 37.  Age main effect of total antagonist muscle coactivation during incline and decline 
walking.  The antagonist muscle coactivation of the BF, VL, TA, and LG normalized to their 
MVC’s were added together to determine the total coactivation.  Old adults had a significantly 
greater total antagonist muscle coactivation than young individuals. * denotes an age main effect 
 
 
 Figure 38 is a summary figure which shows the percent difference between old and 
young antagonist muscle coactivation in each testing condition.  Old individuals had greater 
levels of antagonist muscle coactivation in all muscles in each condition.  These values are also 
shown in Table 7. 
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Figure 38.  Percent difference between young and old antagonist muscle coactivation.  Old had 
greater antagonist muscle coactivation of all muscles in all conditions. 
 
The second sub-hypothesis was that there would be a velocity main effect of antagonist 
muscle coactivation.  The VL had significantly greater antagonist muscle coactivation when 
subjects walked at a self selected speed (an average of 1.0 m/sec) compared to walking at .98 
m/sec (F = 6.626 p = 0.050) and walking at 1.2 m/sec (F = 6.626, p < 0.010).  This is shown in 
Figure 39.  Figures 62-65 in the Appendix show the velocity effect of antagonist muscle 
coactivation of the BF, TA, LG, and total muscle coactivation respectively.  Table 4 also shows 
these values.  There was no significant relationship between increasing walking velocity leading 
to increased antagonist muscle coactivation in these muscles. 
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Figure 39.  Velocity main effect of vastus lateralis antagonist muscle coactivation in old and 
young adults.  Walking at a self selected velocity caused greater coactivation of the VL than 
walking at .98 m/sec and walking at 1.2 m/sec.  ◘ represents a velocity main effect. 
 
 
 The third sub-hypothesis was that walking at a decline would cause greater muscle 
coactivation than walking at an incline.  Walking at a decline elicited significantly greater 
antagonist muscle coactivation of the VL (F = 6.336, p = 0.020).  This is shown in Figure 41.  
During incline walking the BF had greater coactivation (F = 14.697, p = 0.001).  Additionally the 
total amount of antagonist muscle coactivation was greater in incline walking (F = 6.450, p = 
0.019).  These data are shown in Figures 40 and 42 respectively.  The task effect of antagonist 
muscle coactivation of the TA and LG are shown in Figures 66 and 67 in the Appendix.  Table 5 
also shows the values of antagonist muscle coactivation during incline and decline walking. 
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Figure 40.  Task main effect of biceps femoris antagonist muscle coactivation in young and old 
adults.  Incline walking caused significantly greater BF antagonist muscle coactivation.  ◘ 
denotes a significant task main effect. 
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Figure 41.  Task main effect of vastus lateralis antagonist muscle coactivation in old and young 
adults.  Decline walking caused significantly greater VL antagonist muscle coactivation.  ◘ 
denotes a significant task main effect. 
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Figure 42.  Velocity main effect of total antagonist muscle coactivation in old and young adults.  
Walking at an incline caused significantly greater total antagonist muscle coactivation.  ◘ 
denotes a significant task main effect. 
 
 
 Figures 43 and 44 show the significant age by gait velocity interaction effects of 
antagonist muscles.  Figure 43 shows that there was an interaction effect of the VL.  Old 
individuals had significantly greater VL antagonist muscle coactivation than young at self 
selected velocity (F = 7.075, p = 0.050), .98 m/sec (F = 7.075, p < 0.001), and 1.2 m/sec (F = 
7.075, p < 0.001).  Young subjects had significantly greater coactivation of their VL during the 
self selected velocity compared to walking at .98 m/sec (F = 7.075, p < 0.001) and compared to 
walking at 1.2 m/sec (F = 7.075, p < 0.001).  Figure 44 shows that there was also a significant 
interaction effect which occurred in the LG while walking.  Old individuals had significantly 
greater LG antagonist muscle coactivation than the young in the self selected condition (F = 
4.892, p = 0.050) and .98 m/sec (F = 4.892, p < .001).  Additionally old subjects had 
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significantly greater coactivation walking at .98 m/sec compared to walking at 1.2 m/sec (F = 
4.892, p = 0.050).  Figures 68-70 in the Appendix show the coactivation values of the BF, TA, 
and total antagonist muscle respectively, which did not exhibit any interaction effects. 
 During incline and decline walking there were no task by age interaction effects.  The 
antagonist muscle coactivation graphs are shown in Figures 71 through 75 in the Appendix. 
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Figure 43.  Age by velocity interaction effect of vastus lateralis antagonist muscle coactivation 
separated into velocity and age.  Old walking at a self selected velocity had significantly greater 
VL coactivation than young individuals walking at self selected velocities, .98 m/sec, and 1.2 
m/sec.  Old walking at .98 m/sec had significantly greater VL coactivation than young walking at 
.98 m/sec and 1.2 m/sec.  Old walking at 1.2 m/sec had significantly greater VL coactivation 
than young walking at self selected velocities, .98 m/sec, and 1.2 m/sec.  Young walking at self 
selected velocities had significantly greater antagonist muscle coactivation than young walking 
at .98 m/sec and 1.2 m/sec.  * denotes a difference between young and old walking at the same 
velocity.  ◘ denotes a difference between velocities within either the young or old group.  ♠ 
denotes a difference between a different age group and velocity. 
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Figure 44.  Age by velocity interaction effect of lateral gastrocnemeus antagonist muscle 
coactivation separated into velocity and age.  Old walking at a velocity of .98 m/sec had 
significantly greater LG coactivation than old walking at 1.2 m/sec.  Additionally, old walking at 
.98 m/sec had significantly greater LG coactivation than young walking at .98 m/sec.  Finally old 
walking at .98 m/sec had significantly greater VL coactivation than young walking at self 
selected velocities and 1.2 m/sec. ◘ denotes a difference between velocities within either the 
young or old group.  ♠ denotes a difference between a different age group and velocity. 
 
Association between Antagonist Muscle Coactivation and Metabolic Cost 
 The global hypothesis of this study was that the age related increase in metabolic cost 
would be due to increased antagonist muscle coactivation.  Figure 45 shows that this occurred in 
the self selected walking speed condition.  Old adults tended to have both greater antagonist 
muscle coactivation and greater metabolic cost than young adults.  Additionally a correlation of 
r² = .2 could be made between metabolic power and antagonist muscle coactivation showing that 
that there was a moderate but significant association between the variables.  This pattern was 
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also evident in walking at .98 m/sec r² =.36, and walking at 1.2 m/sec r² =.42, and is shown in 
Figures 46 and 47 respectively.   
Figure 48 shows that during incline walking old adults exhibited greater amounts of 
antagonist muscle coactivation; however they did not seem to exhibit greater gross metabolic 
power.  Therefore, during incline walking a strong correlation between total antagonist muscle 
coactivation and gross metabolic power couldn’t be established r² =.06. 
The relationship between gross metabolic power and total antagonist muscle coactivation 
during decline walking are shown in Figure 49.  This relationship is represented by an r² value of 
.42, showing a high correlation between the two variables. 
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Figure 45.  The association of average antagonist muscle coactivation and gross metabolic power 
in level walking at a self-selected velocity.  
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Figure 46.  The association between average antagonist muscle coactivation and gross metabolic 
power in level walking at .98 m/sec.  Old individuals again seemed to have greater antagonist 
muscle coactivation and metabolic power.  An r² value of .36 was computed showing that there 
is a pattern between the two variables. 
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Figure 47.  The association between average antagonist muscle coactivation and gross metabolic 
power in level walking at 1.2 m/sec. 
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Figure 48.  The association between average antagonist muscle coactivation and gross metabolic 
power in incline walking at a 6% grade at .98 m/sec.  There was not a strong correlation between 
the levels of antagonist muscle coactivation and gross metabolic power during this condition. 
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Figure 49.  The association between average antagonist muscle coactivation and gross metabolic 
power in decline walking at a 6% grade at .98 m/sec.  During decline walking old adults seemed 
to experience greater antagonist muscle coactivation and greater metabolic power. 
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Summary 
 
 Statistical analyses have revealed that there are differences between ages with regard to 
both metabolic energy cost and antagonist muscle coactivation.  The current study displayed that 
old individuals used greater amounts of metabolic energy, and greater amounts of antagonist 
muscle coactivation during walking in all conditions tested.   
Velocity and task main effects also occurred.  Velocity main effects were evident in 
nearly all the metabolic variables tested, and also occurred in VL antagonist muscle coactivation.  
Task main effects occurred for nearly all metabolic variables tested, and also occurred in the BF, 
VL, and total antagonist muscle coactivation. 
An age by velocity interaction was found in the VL and LG antagonist muscle 
coactivation levels.  While an age by task interaction existed in the RPE, and RER. 
Additionally relationships existed between the levels of antagonist muscle coactivation 
and metabolic cost in level walking at a self selected velocity, level walking at .98 m/sec, level 
walking at 1.2 m/sec, and decline walking at a 6% at .98 m/sec.  During these conditions old 
adults also appeared to have greater antagonist muscle coactivation and greater gross metabolic 
power than young individuals, thus supporting our global hypothesis. 
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CHAPTER V:  DISCUSSION 
 The purpose of this study was to compare the cost of locomotion and muscle activity in 
antagonist muscles in old and young adults during gait.  Additionally it was to determine if there 
was a relationship between the metabolic cost of gait and the amount of antagonist muscle 
coactivation that people experience.  Previous studies have determined that old individuals 
experience higher amounts of both metabolic cost and antagonist muscle coactivation; however 
the two variables have not yet been linked. 
 This chapter is divided into the following sections:  1) Development of the Hypothesis, 2) 
The Effects of Aging on Metabolic Cost 3) Neurological Changes which Elicit Increased 
Antagonist Muscle Coactivation, 4) The Velocity and Task Effect on Antagonist Muscle 
Coactivation, 5) Age Related Increased Metabolic Cost is Mediated by Increased Antagonist 
Muscle Coactivation, 6) Conclusions 
Development of the Hypothesis 
 Physiological aging causes ample changes in both metabolic and neuromuscular systems.  
These alterations result in increases of both cost of transport during locomotion and antagonist 
muscle coactivation as hypothesized by sub hypothesis one, which stated that old individuals 
would experience greater levels of metabolic cost of gait and antagonist muscle coactivation.  
Previous research has always looked at these two variables as separate entities.  However 
according to the global hypothesis of this study, metabolic cost of gait, and antagonist muscle 
coactivation appear linked and dependent upon each other. 
The Effects of Aging on Metabolic Cost 
 According to the results in this study, older adults experienced greater metabolic cost 
than young adults in all walking conditions.  This age main effect supports the first sub 
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hypothesis of this study and also matches the results of nearly all previous research regarding 
aging to date. 
 The majority of previous research has linked age related increase in metabolic cost to 
decreased mitochondrial function.  As mitochondria work to provide energy to cells they produce 
some byproducts in addition to ATP and other metabolic compounds.  These byproducts are 
reactive oxygen species and are most likely created within the electron transport system (Sanz, 
Stefanastos et al. 2010).  Specifically this occurs when reverse electron transport occurs 
(Schofeld and Wojtczak 2007) or electrons leak out of the chain.  These mitochondrial reactive 
oxygen species not only cause aging related changes but have also been linked to several age-
related diseases such as Parkinson’s, cancer, and diabetes.  An increase in these free radicals has 
been shown to reduce life expectancy in old individuals (Sanz, Pamplona et al. 2006). 
 Mitochondrial reactive oxygen species cause mutations to occur within mitochondrial 
DNA (Harman 2003).  It is still unclear how exactly they cause these mutations, however it has 
been determined that the reactive oxygen species cause mtDNA to fracture and break apart 
thereby contributing to their degradation and mutations (Shokolenko, Venediktova et al. 2009).  
Overtime, if the mitochondria have undergone mutations they tend to cause dysfunction in the 
electron transport system thereby yielding fewer ATP molecules (Dirks, Hofer et al. 2006).  
Since older people have experienced greater levels of mitochondrial reactive oxygen species they 
will have more mutated mitochondria.  If their mitochondria are functioning below their optimal 
level old individuals must increase their metabolic cost in order to perform tasks that otherwise 
would have required less metabolic energy. 
 Even though the mitochondrial dysfunction theory is related to age mediated increases in 
metabolic cost it does not necessarily explain why old adults in this particular study had greater 
  
 
 
 
 
53
metabolic cost.  Although older adults do experience mitochondrial dysfunction it occurs mostly 
in type II muscle fibers, while type I muscle fibers actually become more efficient as people age 
(Deschenes 2004).  Although each muscle is different large motor units and fast twitch muscle 
fibers are not normally activated until at least 60% of max strength (Ives 2005).  As shown in 
Table 8 the old individuals in this study were activating their muscles at levels much lower than 
60% of their max.  Typical values for old normalized muscle strength ranged between 10% and 
30% of their MVCs.  Therefore, the old subjects were clearly utilizing type I muscle fibers while 
walking which means the mitochondria they were using were highly functional.  This forces a 
new conclusion to be made as to why the older individuals experienced greater metabolic cost.  
 The increased metabolic cost that the older individuals experienced in this study was 
most likely caused by higher raw agonist muscle activation, and higher raw antagonist muscle 
activation in old subjects.  Additionally old subjects experienced greater normalized agonist and 
antagonist muscle activation.  When individuals activate their muscles at higher levels they are 
recruiting more motor units, recruiting larger motor units, or increasing the motor units’ firing 
rate (Ives 2005).  As previously mentioned, the old adults in this experiment were most likely not 
using type II muscle fibers, therefore they must have been recruiting more small motor units than 
the young, or they simply had higher motor unit firing rate than the young.  According to Layec 
et al., if individuals recruit more or larger motor units they increase their oxidative cost (Layec, 
Bringard et al. 2009).  Therefore when older individuals have higher muscle activation they will 
in turn have a higher oxidative cost, thereby possibly explaining their greater cost of locomotion 
seen in this study. 
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Neurological Changes which Elicit Increased Antagonist Muscle Coactivation 
 Old adults experienced significantly greater antagonist muscle coactivation than young 
adults in nearly all muscles in every walking condition examined.  This phenomenon may be 
explained by several different possible mechanisms occurring at both the spinal and supraspinal 
regions. 
 As people age they experience decreased reciprocal inhibition.  Reciprocal inhibition is 
controlled at the spinal level through Ia inhibitory motor neurons.  Kido et al. found that in both 
the tibialis anterior and the soleus in older individuals had decreased reciprocal inhibition (Kido, 
Tanaka et al. 2004).  When someone has decreased reciprocal inhibition their interneuron 
actually has a higher resting potential.  In other words, the interneuron and consequentially motor 
neuron and muscle fibers that it innervates will require less electrical activity to become 
stimulated, it is closer to motor threshold.  Therefore, it is easier for old individuals to cause an 
action potential to fire and stimulate an antagonist muscle while the agonist is firing, thus 
increasing the likelihood of antagonist muscle coactivation. 
 Another explanation of increased antagonist muscle coactivation is that old individuals 
experience cortical changes that reduce the suppression of brain areas that control antagonist 
muscle movement.  By reducing suppression of these brain areas antagonist muscles are more 
likely to fire in old individuals.  In fact these muscles are likely to begin firing even before 
movement is necessary.  Hortobagyi and DeVita found that in a downward stepping task, old 
individuals not only had greater levels of both agonist and antagonist muscle activity, but they 
also had greater antagonist muscle activity before the task even started (Hortobagyi and DeVita 
2000).  The action potentials in antagonist muscles that old people experience prior to beginning 
a task most likely come from the brain as a way to prepare the body for what is about to 
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experience.  Although the current study didn’t look at the duration and timing of the antagonist 
muscle contraction it is safe to assume that it was longer in old than young subjects as a way to 
prepare old individuals for the task at hand. 
 Another supra-spinal change that old individuals experience involves the reorganization 
of the brain due to age related neurodegredation.  As people age, they experience changes in their 
dendrites and brain synapse (Levenez, Garland et al. 2008).  The reorganization of the brain 
causes more areas of the brain to be active in old people than in young people during a simple 
task (Capaday, Devanne et al. 1998).  Since more areas of the brain are active in old individuals 
it is possible that they are unintentionally recruiting areas that are not necessary for the task at 
hand.  The cortical connections in older brains could be causing antagonist muscles to activate, 
when really they only need their agonist muscles to fire.  Hutchinson, Kobayashi, et al. found 
that old individuals used significantly more of their brain than young individuals for simple tasks 
such as moving their index finger (Hutchinson, Kobayashi et al. 2002).  The increased brain 
activity old individuals experienced will result in greater muscle activation all around, including 
antagonist muscle activation. 
 These neurological and physiological changes that occur as people age are inventible.  
Even though they weren’t evaluated in this particular study we can assume that they were the 
reasons that old subjects experienced greater levels of antagonist muscle coactivation than young 
subjects. 
Velocity and Task Effect on Antagonist Muscle Coactivation 
 The second and third sub hypotheses were that faster walking velocities would cause 
greater antagonist muscle coactivation and that decline walking would cause greater muscle 
coactivation than incline walking. 
  
 
 
 
 
56
 The only significant velocity main effect that was present in this particular study was 
found in the vastus lateralis during self selected walking speed.  This value was significantly 
lower than vastus lateralis coactivation when walking at both .98 and 1.2 m/sec.  Since the 
average self selected walking speed was 1.0 m/sec it was assumed that antagonist muscle 
coactivation of the .98 m/sec condition would have been nearly the same as the self-selected 
speed, and if anything else slightly lower than the self selected condition.  This however was not 
the case. 
 Hortobagyi et al. previously found that as walking velocity increased antagonist muscle 
coactivation also increased (Hortobagyi, Solnik et al. 2009).  Although it wasn’t significant, the 
current study found that when walking at 1.2 m/sec subjects experienced greater VL, TA, and 
total coactivation than when walking at .98 m/sec.  One possible reason that these values weren’t 
significant could be that neither speed took subject’s out of their comfort zone of walking.  In 
other words, the walking tasks could have been too similar or simple to elicit major velocity 
main effects. 
 Although the values weren’t significant, walking at a self selected velocity elicited the 
greater amounts of antagonist muscle coactivation in the VL, TA, and total muscle than both the 
.98 m/sec and 1.2 m/sec conditions.  Most previous research has shown that while walking at a 
self selected velocity the body naturally picks a pace that elicits the least amount of work (Jones, 
Waters et al. 2009).  In other words the body chooses the path of least resistance.  This was not 
the case in the present study.   
One possible explanation for this phenomenon has to do with testing protocol.  The first 
walking condition that subjects always participated in was walking at a self-selected speed.  
Besides the resting measurement, this was the only condition which was not randomized.  Person 
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once showed that antagonist muscle coactivation is higher in tasks that are unfamiliar to people, 
then decreases as individuals become more familiar with the task they are performing their 
antagonist muscle coactivation decreases (Person and Roshchina 1958).  It is quite possible that 
when the subject’s first started to walk on the treadmill they weren’t given enough time to 
acclimate to it and were still in the learning phase of treadmill walking during the self selected 
condition. 
The third sub-hypothesis was that there would be a condition effect in which walking at a 
decline would cause greater antagonist muscle coactivation than walking at an incline.  This was 
assumed because one of the purposes of antagonist muscle coactivation is to provide support and 
stabilization to joints (Hortobagyi and DeVita 2000).  Additionally during decline walking the 
downward lowering motion that occurs requires greater stabilization in order to promote joint 
longevity and health (Granata, Lee et al. 2005). 
The results of this study showed that decline walking caused significantly greater VL 
coactivation than incline walking.  It also showed that walking at an incline actually produced 
greater antagonist muscle coactivation than walking at a decline in the BF and in total antagonist 
muscle coactivation.  This may have occurred for several different reasons.  Some scientists have 
looked at individuals with previous knee injuries and determined that during inclined treadmill 
walking their hamstring muscles activate significantly earlier.  It is speculated that this is a 
method to increase knee stability during walking (Kalund, Sinkjaer et al. 1990).  Subjects within 
this study, specifically those who had never walked on a treadmill before could have been 
activating their BF more in order to increase their stability in this new task. 
Another possible reason for this refuted sub-hypothesis could have been that the subjects 
were walking on the treadmill itself.  Walking on the treadmill could have elicited different 
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muscle pattern than what would have otherwise been seen in overground walking.  Lee and 
Hidler found that when walking on a treadmill adults experienced greater muscle activation of 
the hamstring during the swing phase of gait.  This could also explain why subjects had greater 
BF coactivation during incline walking (Lee and Hidler 2008). 
A final reason for increased total coactivation during the incline condition could have to 
do with the intensity level at which the subjects were walking.  As shown in Figure 21, subjects 
were working at a significantly higher workload during the incline condition.  Since the intensity 
was greater during the incline condition it could have forced subjects to have greater antagonist 
muscle coactivation compared to walking at a decline when the workload was significantly less.  
Previous research has shown that greater levels of coactivation exist within motions that are 
more intense (Caty, Aujouannet et al. 2007).  Additionally research has shown that as individuals 
fatigue antagonist muscle coactivation also increases (Psek and Cafarelli 1993).  Since the 
subjects within the present study were working at a higher intensity during the incline condition 
they are more likely to demonstrate fatigue in this condition, thereby, leading to their increased 
antagonist muscle coactivation. 
Age Related Increased Metabolic Cost is Mediated by Increased Antagonist Muscle 
 Coactivation 
 As previously mentioned there was a significant age effect in both metabolic cost and 
antagonist muscle coactivation.  Old individuals experienced greater levels of both gross 
metabolic power and antagonist muscle coactivation.  Regression lines were able to be placed in 
Figures 45 through 49.  It appears as though in all conditions except the incline condition there is 
a relationship between the two variables. 
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 The aging process causes inevitable alterations in the body’s neurological, physiological, 
and anatomical systems.  One set of changes already discussed involves increased levels of 
antagonist muscle activity.  As individuals age they experience alterations in their cortical and 
sub cortical nervous system.  These changes include decreased reciprocal inhibition, decreased 
cortical inhibition, a reconfiguration of the brain, and increased brain activity.  All these 
variables lead to age related increases in antagonist muscle coactivation.  They will increase the 
likelihood of the antagonist muscle firing. 
 When antagonist muscles fire they elicit opposing force against the agonist muscles.  This 
opposing force causes the agonist muscles to have to contract stronger in order to overcome the 
power being produced by the antagonist.  Therefore, not only is extra effort put into making the 
antagonist muscle contract, but extra exertion is also used to make the agonist overcome the 
antagonist muscle.  All this extra effort costs the body metabolically.  When greater levels of 
muscle mass are recruited for movement greater amounts of metabolic energy are needed fuel the 
bodies ATP demands (Truijens, Noordermeer et al. 2005). 
  This age related demand in metabolic energy explains why old individuals constantly use 
more energy to complete everyday tasks and activities of daily living (ADL).  Old individuals 
execute tasks at a greater level relative to their maximum amount of effort (Hortobagyi, Mizelle 
et al. 2003).  This is caused by their inefficient movements using relatively high levels of 
antagonist muscle coactivation.   
This pattern was evident in walking at a self selected speed, walking at .98 m/sec, 
walking at 1.2 m/sec, and walking at a decline.  It was not very apparent in the incline walking 
condition.  As shown in Figure 48, old adults still experienced greater levels of antagonist 
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muscle coactivation; however they didn’t experience an increase in metabolic power of the same 
magnitude.   
 The old subjects used for this study were incredibly healthy and highly active for their 
age.  Ten out of the twelve older subjects exercised for at least an hour everyday.  Oftentimes the 
old subjects were more active then the young subjects that were tested.  Five out of the twelve 
young subject’s tested exercised at least an hour a day.  If normal, less active old subjects or 
more active young subjects were used, more drastic results would have been seen, and a stronger 
correlation between antagonist muscle coactivation and gross metabolic power would have been 
evident.  Training status also influences the level of antagonist muscle coactivation present in 
individuals.  Both old and young subjects who were involved in exercise programs experienced 
lower amounts of antagonist muscle coactivation after several weeks of training (LaRoche, Roy 
et al. 2008). 
The findings of the present study are incredibly important for the medical and fitness 
worlds.  Now that we’ve shown that the age related increase in antagonist muscle coactivation 
causes or at least adds to the increased metabolic cost old people experience physicians, 
researchers, and other health professionals can prescribe exercises and fitness routines that will 
reduce antagonist muscle coactivation.  This will in turn reduce metabolic energy demands and 
allow old individuals to complete ADLs at energy levels lower to their maximum capacity.  Old 
adults may be able to increase their overall level of function. 
Conclusions 
 Age was found to affect antagonist muscle coactivation levels in all muscles evaluated in 
both different tasks and at different velocities during gait.  Additionally age affected the amount 
of metabolic energy used in all tasks and velocities during gait.  Old adults experienced 
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significantly greater amounts of antagonist muscle coactivation and metabolic cost than young 
adults.  After using a regression analysis it was observed that the two variables were related.  The 
age related increases in antagonist muscle coactivation seem to contribute to the age related 
increases in metabolic cost.  This suggests that the neural changes associated with aging and 
changes in muscle control ultimately effect old individuals’ energy levels and general ability to 
function at the highest level possible. 
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APPENDIX-A 
Table 1.  Subject characteristics 
 
Characteristic Young  Old 
  Mean   SE   Mean   SE 
Age (years)  *20.9 ± 0.7  * 77.3 ± 1.4 
Height (cm) 175.0 ± 2.5  169.9 ± 2.5 
Mass (kg) 68.4 ± 2.0  70.4 ± 13.5 
BMI 22.3 ± 0.4  24.3 ± 1.0 
Self Selected Walking Speed (m/sec) 1.0 ± 0.1  1.0 ± 0.1 
Resting HR (beats/min) 84.1 ± 4.2  80.3 ± 3.3 
Resting VO2 (ml/min) 302.5 ± 21.8  295.9 ± 21.5 
Resting VO2 (ml/min/kg) 4.4 ± 0.9  4.1 ± 0.6 
                
Values represented as mean ± standard error. 
* represents an age effect between young and old subjects 
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Table 2.  Metabolic variables for level walking conditions 
 
Metabolic Variable Age Velocity   Age   
  Self Selected   .98 m/sec   1.2 m/sec     
  Mean  SE  Mean  SE      Mean  SE 
 
RPE Young 7.8 ± 0.5   8.1 ± 0.6   9.0 ± 0.6   *8.3 ± 0.5 
Old 10.9 ± 0.5  9.8 ± 0.6  11.8 ± 0.6  *10.9 ± 0.5 
Velocity 9.4 ± 0.3  9.0 ± 0.4  ◘10.4 ± 0.4     
 
                
 
HR (b/min) Young 90.0 ± 4.5  80.6 ± 4.1  94.7 ± 4.6  *91.8 ± 4.3 
 
Old 107.8 ± 4.5  105.8 ± 4.1  114.1 ± 4.6  *109.2 ± 4.3 
 
Velocity 98.9 ± 3.2  93.2 ± 2.9  ◘104.4 ± 3.3     
 
                
 
RER Young 0.86 ± 0.02  0.88 ± 0.02  0.86 ± 0.01  *0.87 ± 0.01 
Old 0.83 ± 0.02  0.81 ± 0.02  0.83 ± 0.01  *0.82 ± 0.01 
Velocity 0.84 ± 0.01  0.84 ± 0.01  0.85 ± 0.01     
 
                
 
VO2 (ml/min) Young 847.3 ± 53.2  825.5 ± 50.9  946.6 ± 63.5  873.1 ± 52.1 
Old 1039.3 ± 53.2  960.4 ± 50.9  1084.7 ± 63.5  1018.1 ± 52.1 
Velocity 843.3 ± 37.7  877.9 ± 36.0  ◘1015.6 ± 44.9     
 
                
 
VO2 (ml/min/kg) Young 12.3 ± 0.6  12.0 ± 0.4  13.8 ± 0.4  *12.7 ± 0.4 
Old 14.6 ± 0.6  12.9 ± 0.4  15.0 ± 0.4  *14.2 ± 0.4 
Velocity ◘13.5 ± 0.4  ◘12.5 ± 0.3  ◘14.4 ± 0.3     
                
 
Gross Metabolic Power 
(W/kg) 
Young 4.2 ± 0.2  4.1 ± 0.1  4.7 ± 0.2  *4.3 ± 0.1 
Old 5.0 ± 0.2  4.5 ± 0.1  5.2 ± 0.2  *4.9 ± 0.1 
Velocity 4.6 ± 0.2  4.3 ± 0.1   ◘5.0 ± 0.1     
 
                
 
Gross Metabolic Energy 
Cost per distance 
(W/kg/m) 
Young 4.3 ± 0.2  4.2 ± 0.2  3.9 ± 0.2  *4.2 ± 0.1 
Old 4.9 ± 0.2  4.6 ± 0.2  4.3 ± 0.2  *4.6 ±   0.1 
Condition 4.6 ± 0.1  4.4 ± 0.1  ◘4.1 ± 0.1     
                  
Variables are expressed as mean ± standard error.  
* represents an age effect between young and old subjects 
◘ represents a velocity effect 
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Table 3.  Metabolic variables for task dependent walking conditions 
Metabolic Variable Age Task   Age   
  Incline 6%   Decline 6%     
  Mean  SE  Mean   SE   Mean   SE 
 
RPE Young 9.5 ± 0.6   8.7 ± 0.6  *9.1 ± 0.5 
Old ♠12.8 ± 0.6  ♠10.2 ± 0.6  *11.5 ± 0.5 
Condition ◘11.2 ± 0.5   ◘9.4 ± 0.4      
 
  
 
   
 
   
 
 
 
Young 103.7 ± 4.6  85.2 ± 4.3  *94.5 ± 4.3 
HR (b/min) 
Old 119.4 ± 4.6  99.6 ± 4.3  *109.5 ± 4.3 
 
Condition ◘111.6 ± 3.3  ◘92.4 ± 3.1     
 
  
 
   
 
   
 
 
 
RER Young 0.88 ± 0.02  ♠0.91 ± 0.02  *0.89 ± 0.02 
Old 0.86 ± 0.02  ♠0.83 ± 0.02  *0.84 ± 0.02 
Condition 0.87 ± 0.01  0.87 ± 0.01     
 
  
 
   
 
   
 
 
 
VO2 (ml/min) 
Young 1159.4 ± 55.1  637.0 ± 60.1  898.0 ± 54.0 
Old 1233.6 ± 55.1  809.6 ± 60.1  1021.6 ± 54.0 
Condition ◘1196.5 ± 39.0  ◘723.3 ± 42.5     
 
  
 
   
 
   
 
 
 
VO2 (ml/min/kg) Young 16.9 ± 0.4  9.3 ± 0.5  *13.1 ± 0.3 
Old 17.2 ± 0.4  11.1 ± 0.5  *14.2 ± 0.3 
Condition ◘17.1 ± 0.3  ◘10.2 ± 0.4     
  
 
   
 
   
 
 
 
Gross Metabolic Power (W/kg) Young 5.7 ± 0.1  3.2 ± 0.2  *4.47 ± 0.13 
Old 6.0 ± 0.1  3.8 ± 0.2  *4.92 ± 0.13 
Condition ◘5.9 ± 0.1  ◘3.5 ± 0.1     
 
  
 
   
 
   
 
 
 
Gross Metabolic Energy Cost 
per distance (W/kg/m) 
Young 5.9 ± 0.1  3.3 ± 0.2  *4.56 ± 0.14 
Old 6.1 ± 0.1  3.9 ± 0.2  *5.02 ± 0.14 
Condition ◘6.0 ± 0.1  ◘3.6 ± 0.1       
Variables are expressed as mean ± standard error.  
* represents an age effect between young and old subjects 
◘ represents a condition effect 
♠ represents an age by condition interaction 
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Table 4. Average antagonist muscle coactivation during level walking conditions 
 
Muscle Age Gait Velocity (m/sec)   Age     
  Self Selected   0.98 m/sec   1.2 m/sec     
  Mean  SE  Mean SE  Mean SE  Mean SE 
 
BF Young 5.1 ± 2.5   7.5 ± 3.0   5.3 ± 3.0    *6.0 ± 2.6 
Old 21.7 ± 2.5  21.8 ± 3.0  22.1 ± 3.0  *21.8 ± 2.6 
Velocity 13.4 ± 1.8  14.7 ± 2.1  13.7 ± 2.1   
 
 
 
              
 
 
 
VL Young ♠11.0 ± 1.9  4.2 ± 1.7  4.8 ± 1.7  *6.7 ± 1.5 
Old ♠15.6 ± 1.9  ♠14.9 ± 1.7  ♠16.8 ± 1.7  *15.7 ± 1.5 
Velocity ◘13.3 ± 1.3  9.6 ± 1.2  10.8 ± 1.2   
 
 
 
              
 
 
 
TA Young 5.1 ± 0.8  4.9 ± 0.7  5.6 ± 0.8  *5.1 ± 0.7 
Old 8.0 ± 0.8  6.7 ± 0.7  7.0 ± 0.8  *7.2 ± 0.7 
Velocity 6.5 ± 0.6  6.0 ± 0.5  6.2 ± 0.6   
 
 
 
              
 
 
 
LG Young 3.9 ± 0.8  4.2 ± 0.8  6.6 ± 1.9  *4.9 ± 1.0 
Old 9.1 ± 0.8  ♠14.9 ± 1.7  8.4 ± 1.9  *10.8 ± 1.0 
Velocity 6.5 ± 0.6  9.6 ± 1.2  7.5 ± 1.3   
 
 
 
              
 
 
 
Total Young 25.2 ± 3.9  20.8 ± 4.9  22.1 ± 4.8  *22.7 ± 3.9 
Old 54.3 ± 3.9  52.9 ± 4.9  54.3 ± 4.8  *53.8 ± 3.9 
Velocity 39.7 ± 2.8  36.9 ± 3.4  38.2 ± 3.4     
The average antagonist muscle coactivation is represented by % of the muscles’ maximal 
voluntary contraction.  It is represented by mean ± standard error 
* represents an age effect between young and old subjects 
◘ represents a velocity effect 
♠ represents an age by condition interaction 
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Table 5.  Average antagonist muscle coactivation based upon type of task 
Muscle Age Task   Age   
  Incline 6%   Decline 6%     
  Mean  SE  Mean  SE  Mean  SE 
 
 
BF 
Young 6.4 ± 1.5   4.1 ± 1.7   *5.2 ± 1.4 
Old 22.5 ± 1.5  16.1 ± 1.7  *19.3 ± 1.4 
Condition ◘14.5 ± 1.1  ◘10.1 ± 1.2     
 
  
 
   
 
   
 
 
VL 
Young 4.1 ± 1.5  5.1 ± 1.4  *4.6 ± 1.4 
Old 14.6 ± 1.5  15.4 ± 1.4  *15.0 ± 1.4 
Condition ◘9.3 ± 1.0  ◘10.3 ± 1.0     
 
  
 
   
 
   
 
 
TA Young 5.4 ± 0.7  5.1 ± 0.8  5.2 ± 0.7 
Old 6.1 ± 0.7  7.5 ± 0.8  6.8 ± 0.7 
Condition 5.7 ± 0.5  6.3 ± 0.6     
 
  
 
   
 
   
 
 
LG 
Young 4.7 ± 0.9  4.1 ± 0.8  *4.4 ± 0.8 
Old 7.7 ± 0.9  7.8 ± 0.8  *7.8 ± 0.8 
Condition 6.2 ± 0.6  6.0 ± 0.6     
 
  
 
   
 
   
 
 
Total 
Young 20.6 ± 2.6  18.3 ± 3.1  *19.4 ± 2.7 
Old 50.9 ± 2.6  46.9 ± 3.1  *48.9 ± 2.7 
Condition ◘35.7 ± 1.9  ◘32.6 ± 2.2       
The average antagonist muscle coactivation is represented by % of the muscles’ maximal 
voluntary contraction.  It is represented by mean ± standard error 
* represents an age effect between young and old subjects 
◘ represents a condition effect 
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Table 6. Percent difference between young and old metabolic variables 
Metabolic Variable Condition  
 Self Selected 0.98 m/sec 1.2 m/sec Incline Decline 
RPE 28.4  17.3  23.7  25.7  14.8  
 
          
HR (b/min) 16.5  23.8  17.0  13.1  14.5  
 
          
VO2 (ml/min) 18.5  14.0  12.7  6.0  21.3  
 
          
VO2 (ml/min/kg) 15.8  7.0  8.0  1.9  16.6  
 
          
Gross Metabolic Power (W/kg) 16.0  8.9  9.6  4.2  17.0  
 
          
Gross Metabolic Energy Cost per 
distance (W/kg/m) 
12.2   8.7   9.3   4.2   17.0 
 
Old individuals had higher values of all the variables represented in this table.  The values here 
are the percent differences between young and old. 
 
 
 
Table 7. Percent difference between young and old coactivation values 
Muscle Condition   
 Self Selected 0.98 m/sec 1.2 m/sec Incline Decline 
BF 76.3  65.6  76.0  71.6  74.5  
           
VL 29.5  71.8  71.4  71.9  66.9  
           
TA 36.0  26.6  20.0  11.5  32.0  
           
LG 57.1  71.8  21.4  39.0  47.4  
           
Total Antagonist Muscle 
Coactivation 53.6   60.7   59.3   59.5   61.0   
Old individuals had greater coactivation values in all muscles in all conditions.  The values 
represent the difference between old and young coactivation expressed as a percent. 
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Table 8.  Normalized agonist EMG values Expressed as % MVC. 
                        
Muscle Age Condition 
    Self Selected 0.98 m/sec 1.2 m/sec Incline Decline 
BF Young 5.4  8.1  9.5  8.2  10.2  
 Old 29.0  26.1  28.3  27.3  22.5  
            
VL Young 8.0  5.0  16.8  5.4  7.9  
 Old 22.9  17.5  5.4  20.2  20.0  
            
TA Young 12.4  10.9  11.5  11.6  10.4  
 Old 18.2  18.0  20.8  18.7  17.2  
            
LG Young 11.1  13.2  14.8  20.6  8.7  
  Old 25.3   29.7   29.5   31.3   17.9   
Old individuals experienced greater normalized agonist EMG activity than young individuals.  
 
 
 
Table 9. Raw agonist EMG values 
                        
Muscle Age Condition 
    Self Selected 0.98 m/sec 1.2 m/sec Incline      Decline 
BF Young 0.028  0.029  0.033  0.028  0.036  
 Old 0.034  0.031  0.034  0.032  0.026  
            
VL Young 0.020  0.019  0.022  0.019  0.026  
 Old 0.041  0.032  0.025  0.040  0.036  
            
TA Young 0.073  0.069  0.074  0.077  0.066  
 Old 0.082  0.080  0.092  0.084  0.075  
            
LG Young 0.027  0.030  0.035  0.051  0.020  
  Old 0.041   0.048   0.048   0.050   0.029   
Mean raw EMG activity for young and old subjects.  Old individuals had greater levels of 
activation in all conditions and muscles except for incline LG and decline BF. 
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Table 10. Raw antagonist EMG values 
                        
Muscle Age Condition 
    Self Selected 0.98 m/sec 1.2 m/sec Incline Decline 
BF Young 0.018  0.025  0.018  0.020  0.014  
 Old 0.026  0.026  0.027  0.030  0.019  
            
VL Young 0.014  0.014  0.019  0.015  0.018  
 Old 0.029  0.028  0.031  0.028  0.029  
            
TA Young 0.029  0.029  0.032  0.032  0.033  
 Old 0.036  0.031  0.031  0.029  0.034  
            
LG Young 0.009  0.009  0.014  0.011  0.009  
  Old 0.014   0.015   0.013   0.012   0.012   
Mean raw EMG activity for young and old adults.  Old individuals had greater levels of 
activation in all conditions other than 1.2 m/sec TA and LG.
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Figure 50.  Age and velocity interaction of heart rate.  There were no significant interactions. 
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Figure 51.  Age and velocity interaction of rating of perceived exertion.  There were no 
significant interactions. 
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Figure 52. Age and velocity interaction of respiratory exchange ratio.  There were no significant 
interactions. 
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Figure 53.  Age and velocity interaction of VO2 separated into velocity and age.  There were no 
significant interactions. 
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Figure 54.  Age and velocity interaction of VO2 normalized to body weight.  There were no 
significant interactions. 
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Figure 55.  Age and velocity interaction of gross metabolic power.  There were no significant 
interactions. 
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Figure 56.  Age and velocity interaction of gross metabolic energy cost per distance.  There were 
no significant interactions. 
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Figure 57.  Age by task interaction of HR .  There were no significant interactions. 
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Figure 58.  Age by task interaction of VO2.  There were no significant interactions. 
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Figure 59.  Age by task interaction of VO2 normalized to body weight.  There were no 
significant interactions. 
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Figure 60.  Age by task interaction of gross metabolic power .  There were no significant 
interactions. 
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Figure 61.  Age by task interaction of gross metabolic energy cost per distance .  There were no 
significant interactions. 
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Figure 62.  Velocity main effect of biceps femoris antagonist muscle coactivation in old and 
young adults.  There was no velocity effect for this muscle. 
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Figure 63.  Velocity main effect of tibialis anterior antagonist muscle coactivation in old and 
young adults.  There was no velocity effect for this muscle. 
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Figure 64.  Velocity main effect of lateral gastrocnemeus antagonist muscle coactivation in old 
and young adults.  There was no velocity effect for this muscle. 
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Figure 65.  Velocity main effect of total antagonist muscle coactivation in old and young adults.  
There was no velocity effect. 
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Figure 66.  Task main effect of tibialis anterior antagonist muscle coactivation in old and young 
adults.  There was no task main effect. 
 
0
1
2
3
4
5
6
7
8
Inc line Dec line
A
v
e
ra
g
e
 L
a
te
ra
l 
G
a
s
tr
o
c
n
e
m
e
u
s
 C
o
a
c
ti
v
a
ti
o
n
 (
%
M
V
C
)
 
Figure 67.  Task main effect of lateral gastrocnemeus antagonist muscle coactivation in old and 
young adults.  There was no task main effect. 
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Figure 68.  Age by velocity interaction effect of biceps femoris antagonist muscle coactivation.  
There was no significant interaction effect. 
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Figure 69.  Age by velocity interaction effect of tibialis anterior antagonist muscle coactivation.  
There was no significant interaction effect. 
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Figure 70.  Age by velocity interaction effect of total antagonist muscle coactivation.  There was 
no significant interaction effect. 
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Figure 71.  Age by task interaction effect of biceps femoris antagonist muscle coactivation.  
There was no significant interaction effect. 
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Figure 72.  Age by task interaction effect of vastus lateralis antagonist muscle coactivation.  
There was no significant interaction effect. 
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Figure 73.  Age by task interaction effect of tibialis anterior antagonist muscle coactivation .  
There was no significant interaction effect. 
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Figure 74.  Age by task interaction effect of lateral gastrocnemeus antagonist muscle 
coactivation.  There was no significant interaction effect. 
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Figure 75.  Age by task interaction effect of total antagonist muscle coactivation.  There was no 
significant interaction effect. 
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